Drug Information| Drug ID:   | NPD501 |
| Drug Name:   | Brivudine |
| Molecular Formula:   | C11H13BrN2O5 |
| Canonical SMILES:   | Br/C=C/c1cn([C@H]2C[C@@H]([C@H](O2)CO)O)c(=O)nc1O |
| Standard InCHI:   | "InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1" |
| Standard InCHIKey:   | ODZBBRURCPAEIQ-PIXDULNESA-N |
| Max Developmental Stage:   | Phase 2 |
| Max Developmental Stage Source:   | ChEMBL |
  Structural Similarity Between NPASS Natural Products and NPD501Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
| TTD   | DNCL002755 |
| DrugBank   | |
| ChEMBL   | |
| IUPHAR/BPS   | |
| PharmaGKB   | |
| KEGG Drug   | |
| PubChem CID   | 446727 |
| ChEBI   | |
| CAS Number   |
| Molecular Weight   | 332 |
| ALogP   | -1.5664 |
| MLogP   | 1.79 |
| XLogP   | 0.137 |
| HDA   | 7 |
| HBD   | 3 |
| Rotatable Bonds   | 7 |
| TPSA   | 102.59 |
| RO5 Violation   | 0 |